(TSB) and Trypticase soy agar (TSA) were purchased from Becton-Dickinson, Cockeysville, MD.
Mannitol salt agar (MSA) was purchased from Hardy Diagnostics (Santa Maria, CA). Enzymelinked immunosorbent assay (ELISA) development kits for cytokines detection were purchased from R&D Systems, Inc. (Minneapolis, MN).
Antibacterial assays in presence of salts:
To investigate the activity of peptides in the presence of high salt concentrations, WR12, D-IK-8 and pexiganan were tested against MRSA USA300 in a cation-adjusted MHB or in MHB with added concentrations of NaCl (150 mM) or MgCl2 (2 mM). The MIC was subsequently identified, as described before and according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) 1 To determine the effect of protease digestion on the antimicrobial activity of the peptides, each peptide was first incubated with trypsin at a molar ratio of 500: 1 (peptide: enzyme) in the digestion buffer (50 mM Tris-HCl, pH 7.4) at 37°C for 4 hours. After incubation, the digestion mixture was heated at 80°C for 10 min to halt the enzyme reaction. After these treatments, the procedures conducted were the same as the MIC assay described above.
Membrane permeabilization assay (Calcein leakage assay)
Membrane permeabilization of S. aureus by peptides was monitored and quantified by the leakage of the preloaded fluorescent dye, calcein, as described beforegrown in MHB to logarithmic phase at 37°C. Cells were then harvested by centrifugation, washed twice with PBS, and then adjusted spectrophotometrically to an OD600 of 1.0 (≈10 9 CFU/ml) in PBS containing 10% (vol/vol) MHB. Then MRSA cells were incubated with 3 µM calcein AM for 1 hr at 37°C. Calcein-loaded cells were harvested by centrifugation (3,000 × g, 10 min), suspended in PBS, and diluted to achieve a final inoculum of 10 7 CFU/ml. Aliquots of 100 µL were then added into a sterile black-wall 96-well plate. In case of MRSA USA300, WR12 and D- 
Sub-inhibitory concentration of WR12 and D-IK8 increase the uptake and binding of bodipy vancomycin
We investigated the binding and association of fluorescently labeled vancomycin (bodipy vancomycin) with VRSA a previously described 3 4 . Briefly, VRS10 was incubated with subinhibitory concentration of WR12 and D-IK8 (0.5 X MIC) for one hour and then treated with bodipy vancomycin (16 µg/ml) for 30 minutes. Samples treated with bodipy vancomycin only served as a control. After incubation, bacteria were centrifuged at 9,000×g for 5 min, washed four times with PBS, and resuspended in a small volume of PBS. Bacterial pellets were fixed with 4%
paraformaldehyde, and visualized under 40X oil objective of Nikon A1R multi-photon inverted confocal microscope. The results are given as means ± SD (n = 3; data without error bars indicate that the SD is too small to be seen). 
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